Alveolar Bone Loss, Tooth Loss
Conditions
Keywords
Extraction, Alveolar Ridge Augmentation, Freeze Dried Bone Allograft, Leukocytic Platelet Rich Fibrin, Volumetric Changes, Dense Polytetrafluoroethylene Membrane
Brief summary
A Clinical Trial to study the effectiveness between two, tooth socket grafting materials namely, Freeze Dried Bone Allograft (human derived bone particles) and Leukocytic-Platelet Rich Fibrin (the patient's own centrifuged blood). The purpose of this study is to compare the effects (good and bad) of Bone Allograft to Platelet Rich Fibrin to see which material would be the most effective in maintaining the volume of the gum and bone of the jaw during the healing phase as well as minimizing the amount of pain and/or swelling following tooth extraction.
Detailed description
A prospective,randomized clinical trial will be conducted to determine whether L-PRF, compared to freeze dried bone allograft, will result in comparable volumetric shrinkage of the alveolar ridge and overlying keratinized tissue, following extraction of teeth and socket grafting. This trial aims at obtaining information to determine which material would provide a superior clinical result, as well as reporting on patient related outcomes. The participants will be randomly assigned to two groups. The surgical procedure will be performed by one of five calibrated periodontal residents. Patients will be followed for 2 weeks post-operatively by the same resident, to monitor the healing process and to assess for any complications. Randomization will be achieved using a computerized randomization scheme and will be assigned to one of two groups and allocated by means of a sealed envelope opened on the day of surgery communicated to the surgeon during the surgery by a supervising faculty member. Participants will be block-randomized for each of the 5 operators for balance. Anesthesia will be achieved and soft tissue measurements will be obtained using a periodontal probe. An atraumatic extraction technique will be performed to allow for minimal disturbance of the soft and hard tissue architecture. The extraction socket walls are then assessed and any defects in socket measured with a periodontal probe. Group A: Full thickness mucoperiosteal pouch is created up to \ 3mm apical of the bony crest of the socket with a periosteal elevator. The socket is incrementally filled with mineralized cortical freeze-dried bone allograft and condensed. Group B: Socket is pouched as in group A followed by venipuncture of the antecubital vein with 21G needle and collection of 4-6 vials (10ml each) of venous blood without any additive or anticoagulant. The vials are centrifuged for 12 minutes at 2700 rpm to form L-PRF clots. The socket is incrementally filled with the clots and condensed. Following socket fill, both groups will have the grafts covered by dense polytetrafluoroethylene membrane. The membrane is trimmed and adapted with the borders tucked 2-3mm underneath the gingival tissues. Tissues, graft and membrane are stabilized with 5/0 PTFE sutures. The patients will also receive a pain VAS questionnaire evaluating the post-operative pain 1 and 7 days following surgery. A CBCT with the radiographic stent will be taken within 72 hours of the surgery. 7 days post-op: Sutures will be removed if deemed suitable. The VAS questionnaire will be collected. 6 weeks post op: d-PTFE membrane will be retrieved and discarded using tissue forceps. Alginate impressions will be taken for a surgical guide. 11 weeks post op: Second CBCT will be taken with radiographic surgical stent. Images obtained will be used to analyze and compare the ridge dimensions to those obtained at baseline as well as for surgical implant planning. 12 weeks post op: Soft tissue measurement with periodontal probe and floss spanned over edentulous site from buccal to lingual mucogingival junction. Implant placement will be done per standard procedure. A 2.5mm diameter trephine drill will be used to harvest a bone core for histologic analysis. The bone core will be immediately submerged in a solution of 10% neutral buffered formalin. Osteotomies and implant placement will be done following the manufacturer's protocol. Depending on the buccal bone and soft tissue thickness, ancillary soft tissue augmentation, bone augmentation or combination of these procedures may be indicated. The patient will be followed up and referred to the restorative dentist as per standard procedure. Photographs will be taken at every visit.
Interventions
BIOLOGICALFreeze Dried Bone Allograft
Human derived bone particles used in oral and periodontal grafting procedures
BIOLOGICALL-PRF clot
L-PRF is a second-generation platelet rich plasma obtained from autologous blood and contains several different growth factors, platelets and leucocytes in a complex fibrin matrix to accelerate the healing of soft and hard tissues.
Sponsors
University of Manitoba
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
A prospective,randomized clinical trial will be conducted. The trial aims at obtaining information to determine which material would provide a superior clinical result, as well as reporting on patient related outcomes. 42 participants will be randomly assigned to two groups and a direct comparison will be made between the results obtained from the two groups.
Eligibility
Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subjects with molars or premolars indicated for extraction. * Patients that present with a post extraction class I and II socket (\<30% bone loss on the buccal or lingual plate, measured from the most coronal aspect of intact bone to the most apical aspect of the defect divided by the measurement from the most apical aspect of the defect to the apex of the socket x 100). * Patients presenting with the need for single extractions. * Patients with general good health that does not have a condition contra-indicating routine dental treatment, extraction and implant placement. * Patients that are compliant with the research protocol and methods. * Patients that have read, understood and signed an informed consent form.
Exclusion criteria
* Extraction and ridge preservation indicated for teeth other than premolars and molars. * Patients that present with a post extraction class III socket (\>30% bone loss on the buccal or lingual plate, measured from the most coronal aspect of intact bone to the most apical aspect of the defect divided by the measurement from the most apical aspect of the defect to the apex of the socket x 100) * Patients deemed eligible for immediate implant placement following extraction and intra-operative assessment by the attending supervisor. * Patients that present with an oral-antral communication, post extraction. * Patients that presents with the need for multiple, side by side extractions. * Patients with coagulation disorders, on corticosteroids, uncontrolled diabetes mellitus, or any systemic disease where periodontal surgery is contraindicated and healing may be compromised. * Pregnant and nursing women. * Patients with any contact hypersensitivity to the related materials used in the study. * Heavy tobacco users, \>10 cigarettes per day. * Patients unwilling to sign consent or follow the protocol of the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall Horizontal Change in Alveolar Ridge Width | Difference reported on horizontal changes comparing CBCT analysis 11weeks after extraction and grafting compared to CBCT following extraction and grafting | Calculated mean of post operative CBCT measurements of horizontal alveolar bone width changes following extraction and alveolar ridge preservation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Buccolingual Change in Width of Keratinized Soft Tissue | Soft tissue measurement at time of extraction and grafting and 12 weeks after extraction and grafting | Difference in post operative measurement analysis of keratinized gingiva changes following extraction and alveolar ridge preservation |
| Post-operative Pain and Swelling | Measured at 7 days following extraction and grafting | Post-operative pain and complications measured by VAS-questionnaire obtained following extraction and grafting. The VAS-questionnaire contained the following categories to be answered 7days post-operatively: Pain, Swelling. A visual line scale of 100mm in length was provided with no pain/swelling on the one end and severe pain/swelling on the opposite end. Participants were instructed to rate their pain and swelling by marking a single line on the scale indicating the degree of pain/swelling they experienced. Markings were physically measured on the scale and converted into a score with 0 representing no pain/swelling and 1 representing severe pain/swelling. |
Countries
Canada
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Freeze Dried Bone Allograft Socket filled with Mineralized Cortical Freeze Dried Bone Allograft
Freeze Dried Bone Allograft: Human derived bone particles used in oral and periodontal grafting procedures | 14 |
| L-PRF Clot Socket filled with L-PRF Clot
L-PRF clot: L-PRF is a second-generation platelet rich plasma obtained from autologous blood and contains several different growth factors, platelets and leucocytes in a complex fibrin matrix to accelerate the healing of soft and hard tissues. | 12 |
| Total | 26 |
Baseline characteristics
| Characteristic | Freeze Dried Bone Allograft | L-PRF Clot | Total |
|---|---|---|---|
| Age, Continuous | 61.43 years STANDARD_DEVIATION 12.92 | 63.33 years STANDARD_DEVIATION 14.66 | 62.31 years STANDARD_DEVIATION 13.5 |
| Buccolingual Keratinised Tissue Width | 15.25 Millimeters STANDARD_DEVIATION 5.32 | 16.4 Millimeters STANDARD_DEVIATION 4.39 | 15.8 Millimeters STANDARD_DEVIATION 4.8 |
| Buccolingual Ridge Width measured 1mm from crest | 11.38 Millimeters STANDARD_DEVIATION 2.4 | 11.28 Millimeters STANDARD_DEVIATION 1.41 | 11.3 Millimeters STANDARD_DEVIATION 1.8 |
| Buccolingual Ridge Width measured 3mm from crest | 11.82 Millimeters STANDARD_DEVIATION 2.37 | 12.20 Millimeters STANDARD_DEVIATION 1.53 | 12 Millimeters STANDARD_DEVIATION 1.9 |
| Buccolingual Ridge Width measured 5mm from crest | 12.17 Millimeters STANDARD_DEVIATION 2.49 | 12.47 Millimeters STANDARD_DEVIATION 1.94 | 12.3 Millimeters STANDARD_DEVIATION 2.2 |
| Race and Ethnicity Not Collected | — | — | 0 Participants |
| Region of Enrollment Canada | 14 participants | 12 participants | 26 participants |
| Sex: Female, Male Female | 5 Participants | 3 Participants | 8 Participants |
| Sex: Female, Male Male | 9 Participants | 9 Participants | 18 Participants |
| Thickness of buccal plate measured at 1mm from crest | 0.98 Millimeters STANDARD_DEVIATION 0.5 | 0.89 Millimeters STANDARD_DEVIATION 0.3 | 0.93 Millimeters STANDARD_DEVIATION 0.4 |
| Thickness of buccal plate measured at 3mm from crest | 1.08 Millimeters STANDARD_DEVIATION 0.8 | 1.31 Millimeters STANDARD_DEVIATION 0.58 | 1.19 Millimeters STANDARD_DEVIATION 0.69 |
| Thickness of buccal plate measured at 5mm from crest | 1.26 Millimeters STANDARD_DEVIATION 0.98 | 1.50 Millimeters STANDARD_DEVIATION 0.64 | 1.38 Millimeters STANDARD_DEVIATION 0.8 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 14 | 0 / 12 |
| other Total, other adverse events | 7 / 14 | 3 / 12 |
| serious Total, serious adverse events | 0 / 14 | 0 / 12 |
Outcome results
Primary
Overall Horizontal Change in Alveolar Ridge Width
Calculated mean of post operative CBCT measurements of horizontal alveolar bone width changes following extraction and alveolar ridge preservation.
Time frame: Difference reported on horizontal changes comparing CBCT analysis 11weeks after extraction and grafting compared to CBCT following extraction and grafting
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Freeze Dried Bone Allograft | Overall Horizontal Change in Alveolar Ridge Width | -1.34 Millimeters | Standard Error 0.38 |
| L-PRF Clot | Overall Horizontal Change in Alveolar Ridge Width | -2.21 Millimeters | Standard Error 0.41 |
Secondary
Buccolingual Change in Width of Keratinized Soft Tissue
Difference in post operative measurement analysis of keratinized gingiva changes following extraction and alveolar ridge preservation
Time frame: Soft tissue measurement at time of extraction and grafting and 12 weeks after extraction and grafting
Population: Only nine patients had implants placed within the exact specified 12 week timeframe from the date of extraction, therefore data collection and analysis were only performed on these participants.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Freeze Dried Bone Allograft | Buccolingual Change in Width of Keratinized Soft Tissue | -1 Millimeters | Standard Error 3.03 |
| L-PRF Clot | Buccolingual Change in Width of Keratinized Soft Tissue | -4 Millimeters | Standard Error 2.7 |
Secondary
Post-operative Pain and Swelling
Post-operative pain and complications measured by VAS-questionnaire obtained following extraction and grafting. The VAS-questionnaire contained the following categories to be answered 7days post-operatively: Pain, Swelling. A visual line scale of 100mm in length was provided with no pain/swelling on the one end and severe pain/swelling on the opposite end. Participants were instructed to rate their pain and swelling by marking a single line on the scale indicating the degree of pain/swelling they experienced. Markings were physically measured on the scale and converted into a score with 0 representing no pain/swelling and 1 representing severe pain/swelling.
Time frame: Measured at 7 days following extraction and grafting
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Freeze Dried Bone Allograft | Post-operative Pain and Swelling | 0.22 score on a scale | Standard Deviation 0.29 |
| L-PRF Clot | Post-operative Pain and Swelling | 0.23 score on a scale | Standard Deviation 0.3 |